Skip to main content

Bioanalysis Zone is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Awards
  • Events
  • Features
    • An author's perspective
    • Ask the Experts
    • Conference reports
    • eBooks
    • Expert opinion
    • In the Zone
    • Journal articles
    • Journal content
    • Spotlights
    • Tech Digest

    Follow us on social media

  • Glossary
  • Topics
    • Applications
      • Advanced therapies
      • Biomarkers
      • Clinical
      • Diagnostics
      • Drug development
      • Forensics
      • Patient-centric sampling
      • Sports drug testing
      • Toxicology
      • Vaccines
    • Industry updates & regulations
      • Biopharmaceuticals
      • Collaborations & mergers
      • Data processing and interpretation
      • Regulated bioanalysis
    • Molecules
      • Antibodies | ADCs
      • Biosimilars
      • Large molecules
      • Metabolites
      • Oligonucleotides
      • Small molecules
    • Techniques
      • Automation
      • Chromatography
      • Imaging
      • LBA
      • Microsampling
      • MS (LC–MS/MS, HRMS, IMS)
      • Sample preparation

    Follow us on social media

  • Multimedia
    • Coffee chats
    • Infographics
    • Interviews
    • Panel discussions
    • Podcasts
    • Videos
    • Webinars

    Follow us on social media

  • News
  • Partners
  • Register
WEBINAR | Mastering B-cell biomarker tracking in autoimmune therapy 11 days 0 hours 19 mins 39 secs SAVE YOUR SEAT!

Infographic: trends in LBA

3 Sep 2019
General interest

As part of our Spotlight on LBA, we carried out a survey to gain an insight into the trends, challenges and developments associated with this technique. We would like to thank everyone who was able to share their thoughts by taking part in the survey – you can see the results below in our infographic.

LBA spotlight infographic

Top content

  • How blockchain and AI are transforming data integrity in bioanalysis
  • Onsite media partners confirmed for PharmSci 360 2025
  • Novartis to acquire Avidity Biosciences in $12B deal to boost RNA therapeutics pipeline

Related tags

infographic ligand-binding assay
Previous article Next article

Related articles

19 JUN 2019 GENERAL INTEREST
How to get it right the first time: the feasibility of singlet analysis for ligand binding assays
17 FEB 2025 JOURNAL ARTICLES
Cross-validation of pharmacokinetic assays post-ICH M10 is not a pass/fail criterion
16 MAR 2020 GENERAL INTEREST
Chromatographic separation technologies: infographic
25 OCT 2017 JOURNAL ARTICLES
Parallelism experiments to evaluate matrix effects, selectivity and sensitivity in ligand-binding assay method development: pros and cons
4 APR 2018 GENERAL INTEREST
High sensitivity intact monoclonal antibody (mAb) HRMS quantification
6 JUL 2022 JOURNAL ARTICLES
Feasibility of singlicate-based analysis in bridging ADA assay on Meso-Scale Discovery platform: comparison with duplicate analysis
  • About
  • Advertising & Sponsorship
  • Learn
    • Awareness
    • Education zone
    • Professional development
  • Contact Us
  • Permissions
  • Products
  • Zone Leaders
  • Whitelist Emails
  • Accessibility

Contact

Contact Us

Office info

Bioanalysis Zone is powered by Taylor & Francis Group

Bioanalysis Zone, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2025 Bioanalysis Zone